Download PDF
Semin Liver Dis 2013; 33(03): 282-292
DOI: 10.1055/s-0033-1351783
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hepatocellular Carcinoma: Resection versus Transplantation

Truman M. Earl
1   Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of Mississippi Medical Center, Jackson, Mississippi
,
William C. Chapman
2   Section of Transplantation, Department of Surgery, Washington University, St. Louis, Missouri
› Author Affiliations
Further Information

Publication History

Publication Date:
13 August 2013 (online)

    Permissions and Reprints

Abstract

Hepatic resection and transplantation remain the standard curative therapies for hepatocellular carcinoma. These treatments are limited to either patients with early-stage tumors in the case of transplantation or patients with preserved liver function in the case of resection. Currently, patients with early-stage tumors and advanced liver disease are best served by transplant evaluation; however, the best treatment strategy for patients with well-preserved liver function, absence of portal hypertension, and early-stage HCC is debated. Numerous retrospective studies have documented better disease-free survival with transplantation, although the benefit on overall survival is less clear. This effect is likely due to the availability of effective liver-directed therapies for recurrence postresection and the effect of immunosuppression on tumor progression following posttransplant recurrence. Survival studies based on intention-to-treat principle incorporating patients listed for transplantation, but did not undergo the procedure due to waitlist dropoff have also suggested that overall survival rates may not be different despite high recurrence rates following resection. Transplantation has been shown to offer a survival advantage beyond 5-years; however, improvements in adjuvant therapies may narrow this gap. Determining optimal therapy for an individual patient requires consideration of numerous factors including tumor stage, severity of liver disease, and comorbidities as well as geographic and logistical factors that may affect transplant availability.

Keywords

hepatocellular carcinoma - hepatic resection - liver transplantation - intention-to-treat - salvage transplantation
 

  • References

  • 1 Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003; 38 (Suppl. 01) S136-S149
    PubMedGoogle Scholar
  • 2 Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19 (3) 329-338
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Mazzaferro V, Regalia E, Doci R , et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334 (11) 693-699
    CrossrefPubMedGoogle Scholar
  • 4 Tsoulfas G, Kawai T, Elias N , et al. Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol 2011; 46 (2) 249-256
    CrossrefPubMedGoogle Scholar
  • 5 Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis WD, Jenkins RL. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg 2005; 140 (4) 353-358
    CrossrefPubMedGoogle Scholar
  • 6 Trevisani F, Cantarini MC, Labate AM , et al; Italian Liver Cancer (ITALICA) group. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004; 99 (8) 1470-1476
    CrossrefPubMedGoogle Scholar
  • 7 Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001; 16 (5) 553-559
    CrossrefPubMedGoogle Scholar
  • 8 Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130 (7) 417-422
    PubMedGoogle Scholar
  • 9 Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31 (2) 330-335
    CrossrefPubMedGoogle Scholar
  • 10 Sharma P, Balan V, Hernandez JL , et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10 (1) 36-41
    CrossrefPubMedGoogle Scholar
  • 11 Washburn K. Model for end stage liver disease and hepatocellular carcinoma: a moving target. Transplant Rev (Orlando) 2010; 24 (1) 11-17
    CrossrefPubMedGoogle Scholar
  • 12 Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35 (3) 519-524
    CrossrefPubMedGoogle Scholar
  • 13 Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218 (2) 145-151
    CrossrefPubMedGoogle Scholar
  • 14 Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30 (6) 1434-1440
    CrossrefPubMedGoogle Scholar
  • 15 Poon RT, Fan ST, Lo CM , et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234 (1) 63-70
    CrossrefPubMedGoogle Scholar
  • 16 Belghiti J, Regimbeau JM, Durand F , et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 2002; 49 (43) 41-46
    PubMedGoogle Scholar
  • 17 Cha CH, Ruo L, Fong Y , et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003; 238 (3) 315-321 , discussion 321–323
    PubMedGoogle Scholar
  • 18 Bilimoria MM, Lauwers GY, Doherty DA , et al; International Cooperative Study Group on Hepatocellular Carcinoma. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001; 136 (5) 528-535
    CrossrefPubMedGoogle Scholar
  • 19 Llovet JM, Fuster J, Bruix J. Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004; 10 (2) (Suppl. 01) S115-S120
    CrossrefPubMedGoogle Scholar
  • 20 Yao FY, Bass NM, Nikolai B , et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8 (10) 873-883
    CrossrefPubMedGoogle Scholar
  • 21 Yao FY, Ferrell L, Bass NM , et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33 (6) 1394-1403
    CrossrefPubMedGoogle Scholar
  • 22 Bharat A, Brown DB, Crippin JS , et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 2006; 203 (4) 411-420
    CrossrefPubMedGoogle Scholar
  • 23 Chapman WC, Majella Doyle MB, Stuart JE , et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 2008; 248 (4) 617-625
    PubMedGoogle Scholar
  • 24 Bralet MP, Régimbeau JM, Pineau P , et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000; 32 (2) 200-204
    CrossrefPubMedGoogle Scholar
  • 25 Grando-Lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol 1999; 31 (3) 508-513
    CrossrefPubMedGoogle Scholar
  • 26 El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004; 39 (3) 798-803
    CrossrefPubMedGoogle Scholar
  • 27 Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 2002; 194 (5) 592-602
    CrossrefPubMedGoogle Scholar
  • 28 Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford) 2005; 7 (1) 42-49
    CrossrefPubMedGoogle Scholar
  • 29 Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004; 198 (3) 356-365
    CrossrefPubMedGoogle Scholar
  • 30 Vauthey JN, Klimstra D, Franceschi D , et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169 (1) 28-34 , discussion 34–35
    CrossrefPubMedGoogle Scholar
  • 31 Ercolani G, Grazi GL, Ravaioli M , et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003; 237 (4) 536-543
    CrossrefPubMedGoogle Scholar
  • 32 Roayaie S, Obeidat K, Sposito C , et al. Resection of hepatocellular cancer </= 2 cm: results from two western centers. Hepatology 2013; 57 (4) 1426-1435
    CrossrefPubMedGoogle Scholar
  • 33 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229 (2) 216-222
    CrossrefPubMedGoogle Scholar
  • 34 Li Q, Wang J, Juzi JT , et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J Gastrointest Surg 2008; 12 (9) 1540-1547
    CrossrefPubMedGoogle Scholar
  • 35 Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003; 199 (3) 345-353
    CrossrefPubMedGoogle Scholar
  • 36 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235 (3) 373-382
    CrossrefPubMedGoogle Scholar
  • 37 Imamura H, Matsuyama Y, Tanaka E , et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38 (2) 200-207
    PubMedGoogle Scholar
  • 38 Poon RT, Fan ST, O'Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002; 195 (3) 311-318
    CrossrefPubMedGoogle Scholar
  • 39 Iwatsuki S, Gordon RD, Shaw Jr BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202 (4) 401-407
    CrossrefPubMedGoogle Scholar
  • 40 O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207 (4) 373-379
    CrossrefPubMedGoogle Scholar
  • 41 Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW. Is liver transplantation justified for the treatment of hepatic malignancies?. Arch Surg 1990; 125 (10) 1261-1266 , discussion 1266–1268
    CrossrefPubMedGoogle Scholar
  • 42 Onaca N, Davis GL, Jennings LW, Goldstein RM, Klintmalm GB. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2009; 15 (6) 574-580
    CrossrefPubMedGoogle Scholar
  • 43 Shetty K, Timmins K, Brensinger C , et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10 (7) 911-918
    CrossrefPubMedGoogle Scholar
  • 44 Llovet JM, Bruix J, Fuster J , et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998; 27 (6) 1572-1577
    CrossrefPubMedGoogle Scholar
  • 45 Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003; 21 (23) 4329-4335
    CrossrefPubMedGoogle Scholar
  • 46 Freeman Jr RB, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000; 6 (5) 543-552
    CrossrefPubMedGoogle Scholar
  • 47 Organ Procurement and Transplantation Network. Organ Procurement and Transplantation Network. Health Resources and Services Administration, HHS. Final rule. Fed Regist 1999; 64 (202) 56650-56661
    PubMedGoogle Scholar
  • 48 Wiesner RH, McDiarmid SV, Kamath PS , et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7 (7) 567-580
    CrossrefPubMedGoogle Scholar
  • 49 Wiesner R, Edwards E, Freeman R , et al; United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124 (1) 91-96
    CrossrefPubMedGoogle Scholar
  • 50 Olthoff KM, Brown Jr RS, Delmonico FL , et al. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl 2004; 10 (10) (Suppl. 02) A6-A22
    CrossrefPubMedGoogle Scholar
  • 51 Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10 (1) 7-15
    CrossrefPubMedGoogle Scholar
  • 52 Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127 (5) (Suppl. 01) S261-S267
    CrossrefPubMedGoogle Scholar
  • 53 Sharma P, Harper AM, Hernandez JL , et al. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant 2006; 6 (8) 1957-1962
    CrossrefPubMedGoogle Scholar
  • 54 Duffy JP, Vardanian A, Benjamin E , et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007; 246 (3) 502-509 , discussion 509–511
    CrossrefPubMedGoogle Scholar
  • 55 Onaca N, Klintmalm GB. Liver transplantation for hepatocellular carcinoma: the Baylor experience. J Hepatobiliary Pancreat Sci 2010; 17 (5) 559-566
    CrossrefPubMedGoogle Scholar
  • 56 Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001; 33 (5) 1073-1079
    CrossrefPubMedGoogle Scholar
  • 57 Pelletier SJ, Fu S, Thyagarajan V , et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009; 15 (8) 859-868
    CrossrefPubMedGoogle Scholar
  • 58 Maddala YK, Stadheim L, Andrews JC , et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004; 10 (3) 449-455
    CrossrefPubMedGoogle Scholar
  • 59 Mazzaferro V, Battiston C, Perrone S , et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240 (5) 900-909
    CrossrefPubMedGoogle Scholar
  • 60 Llovet JM, Real MI, Montaña X , et al; Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359 (9319) 1734-1739
    CrossrefPubMedGoogle Scholar
  • 61 Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37 (2) 429-442
    CrossrefPubMedGoogle Scholar
  • 62 Lo CM, Ngan H, Tso WK , et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35 (5) 1164-1171
    CrossrefPubMedGoogle Scholar
  • 63 Yao FY, Kinkhabwala M, LaBerge JM , et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005; 5 (4 Pt 1) 795-804
    CrossrefPubMedGoogle Scholar
  • 64 Roayaie S, Frischer JS, Emre SH , et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235 (4) 533-539
    CrossrefPubMedGoogle Scholar
  • 65 Kneteman NM, Oberholzer J, Al Saghier M , et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 2004; 10 (10) 1301-1311
    CrossrefPubMedGoogle Scholar
  • 66 Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007; 13 (3) 391-399
    CrossrefPubMedGoogle Scholar
  • 67 Majno PE, Adam R, Bismuth H , et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226 (6) 688-701 , discussion 701–703
    CrossrefPubMedGoogle Scholar
  • 68 Yao FY, Kerlan Jr RK, Hirose R , et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008; 48 (3) 819-827
    CrossrefPubMedGoogle Scholar
  • 69 Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 2012; 55 (1) 132-140
    CrossrefPubMedGoogle Scholar
  • 70 Facciuto ME, Rochon C, Pandey M , et al. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) 2009; 11 (5) 398-404
    CrossrefPubMedGoogle Scholar
  • 71 Sogawa H, Shrager B, Jibara G, Tabrizian P, Roayaie S, Schwartz M. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) 2013; 15 (2) 134-141
    CrossrefPubMedGoogle Scholar
  • 72 Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11 (10) 1242-1251
    CrossrefPubMedGoogle Scholar
  • 73 Nathan H, Bridges JF, Schulick RD , et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol 2011; 29 (6) 619-625
    CrossrefPubMedGoogle Scholar
  • 74 Nathan H, Segev DL, Bridges JF , et al. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol 2013; 20 (2) 448-456
    CrossrefPubMedGoogle Scholar
  • 75 Sapisochin G, Castells L, Dopazo C , et al. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol 2013; 20 (4) 1194-1202
    CrossrefPubMedGoogle Scholar
  • 76 Dhir M, Lyden ER, Smith LM, Are C. Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB (Oxford) 2012; 14 (9) 635-645
    CrossrefPubMedGoogle Scholar
  • 77 Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 2010; 101 (1) 47-53
    CrossrefPubMedGoogle Scholar
  • 78 Baccarani U, Isola M, Adani GL , et al. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transpl Int 2008; 21 (3) 247-254
    CrossrefPubMedGoogle Scholar
  • 79 Bellavance EC, Lumpkins KM, Mentha G , et al. Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?. J Gastrointest Surg 2008; 12 (10) 1699-1708
    CrossrefPubMedGoogle Scholar
  • 80 Del Gaudio M, Ercolani G, Ravaioli M , et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008; 8 (6) 1177-1185
    CrossrefPubMedGoogle Scholar
  • 81 Shah SA, Cleary SP, Tan JC , et al. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol 2007; 14 (9) 2608-2614
    CrossrefPubMedGoogle Scholar
  • 82 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007; 245 (1) 51-58
    CrossrefPubMedGoogle Scholar
  • 83 Bigourdan JM, Jaeck D, Meyer N , et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9 (5) 513-520
    CrossrefPubMedGoogle Scholar
  • 84 Weimann A, Schlitt HJ, Oldhafer KJ, Hoberg S, Tusch G, Raab R. Is liver transplantation superior to resection in early stage hepatocellular carcinoma?. Transplant Proc 1999; 31 (1-2) 500-501
    CrossrefPubMedGoogle Scholar
  • 85 Adam R, Azoulay D. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?. Ann Surg 2005; 241 (4) 671-672
    CrossrefPubMedGoogle Scholar
  • 86 Belghiti J, Cortes A, Abdalla EK , et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238 (6) 885-892 , discussion 892–893
    CrossrefPubMedGoogle Scholar
  • 87 Adam R, Azoulay D, Castaing D , et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg 2003; 238 (4) 508-518 , discussion 518–519
    PubMedGoogle Scholar
  • 88 Cucchetti A, Vitale A, Gaudio MD , et al. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 2010; 10 (3) 619-627
    CrossrefPubMedGoogle Scholar